Xeris Pharmaceuticals, Inc.is a pharmaceutical company, which develops and commercializes ready-to-use, liquid-stable injectables. It offers XeriSol™ and XeriJect™ formulation technologies. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Austin, TX.
I bought XERS initially at 9.23 and have since then swung it from 11.50 to 12.50+ area. I believe it is heading into a short term bear trend which will precipitate a run up to the FDA PDUFA approval of it's diabetic non inject able. Short ratio is up as well.
I marked the resistance and support points that I think are major. There are no triangles to work off of...